Cargando…

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease

In neuronal systems, the health and activity of mitochondria and synapses are tightly coupled. For this reason, it has been postulated that mitochondrial abnormalities may, at least in part, drive neurodegeneration in conditions such as Alzheimer’s disease (AD). Mounting evidence from multiple Alzhe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calkins, Marcus J., Manczak, Maria, Reddy, P. Hemachandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513393/ https://www.ncbi.nlm.nih.gov/pubmed/23226091 http://dx.doi.org/10.3390/ph5101103

Ejemplares similares

Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31
por: Reddy, Tejaswini P., et al.
Publicado: (2011)

Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease
por: Reddy, P Hemachandra, et al.
Publicado: (2016)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma
por: PANG, Yu, et al.
Publicado: (2015)

Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2011)

Exosomes as Carriers of Alzheimer's Amyloid-ß
por: Yuyama, Kohei, et al.
Publicado: (2017)

SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease
por: Zhu, Yuexin, et al.
Publicado: (2022)

Amyloid-Beta Interaction with Mitochondria
por: Pagani, Lucia, et al.
Publicado: (2011)

Amyloid-ß-directed immunotherapy for Alzheimer's disease
por: Lannfelt, L, et al.
Publicado: (2014)

Combined Therapy with SS31 and Mitochondria Mitigates Myocardial Ischemia-Reperfusion Injury in Rats
por: Lee, Fan-Yen, et al.
Publicado: (2018)

Mitochondrial Oxidative Damage in Aging and Alzheimer's Disease: Implications for Mitochondrially Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2006)

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

CART Peptide Is a Potential Endogenous Antioxidant and Preferentially Localized in Mitochondria
por: Mao, Peizhong, et al.
Publicado: (2012)

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
por: Ding, Yu, et al.
Publicado: (2019)

New Insights in the Amyloid-Beta Interaction with Mitochondria
por: Spuch, Carlos, et al.
Publicado: (2012)

Mitochondria Are Related to Synaptic Pathology in Alzheimer's Disease
por: Baloyannis, Stavros J.
Publicado: (2011)

Targeting mitochondria in the aged cerebral vasculature with SS-31, a proteomic study of brain microvessels
por: Seman, Abigail, et al.
Publicado: (2023)

Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention
por: Marsh, Jade, et al.
Publicado: (2018)

Amyloid-Beta Mediates Homeostatic Synaptic Plasticity
por: Galanis, Christos, et al.
Publicado: (2021)

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
por: Zhao, Weixing, et al.
Publicado: (2019)

Intracellular Accumulation of Amyloid-Beta – A Predictor for Synaptic Dysfunction and Neuron Loss in Alzheimer's Disease
por: Bayer, Thomas A., et al.
Publicado: (2010)

Beta-Amyloid Instigates Dysfunction of Mitochondria in Cardiac Cells
por: Jang, Sehwan, et al.
Publicado: (2022)

Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia
por: Zhao, Hongting, et al.
Publicado: (2017)

Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia
por: Ballarò, Riccardo, et al.
Publicado: (2021)

Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
por: Kline, Adam
Publicado: (2012)

Selected microRNAs Increase Synaptic Resilience to the Damaging Binding of the Alzheimer’s Disease Amyloid Beta Oligomers
por: Zolochevska, Olga, et al.
Publicado: (2020)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity
por: Manczak, Maria, et al.
Publicado: (2019)

Corrigendum: Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity
por: Manczak, Maria, et al.
Publicado: (2019)

Synthesis, Characterization, and Specific Localization of Mitochondrial-Targeted Antioxidant Peptide SS31 Probe
por: He, Yuan, et al.
Publicado: (2021)

Abnormalities of synaptic mitochondria in autism spectrum disorder and related neurodevelopmental disorders
por: Rojas-Charry, Liliana, et al.
Publicado: (2020)

The effect of ghrelin on antioxidant status in the rat’s model of Alzheimer’s disease induced by amyloid-beta
por: Sarlaki, Fatemeh, et al.
Publicado: (2022)

Dementia of the eye: the role of amyloid beta in retinal degeneration
por: Ratnayaka, J A, et al.
Publicado: (2015)

Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
por: Fernandez‐Perez, Eduardo J., et al.
Publicado: (2021)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

Dysfunctional Mitochondrial Bioenergetics and Synaptic Degeneration in Alzheimer Disease
por: Tang, Jason, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r7eplpidq5mt2um9n4upup6fk2